1. Home
  2. NTRA vs ADM Comparison

NTRA vs ADM Comparison

Compare NTRA & ADM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • ADM
  • Stock Information
  • Founded
  • NTRA 2003
  • ADM 1902
  • Country
  • NTRA United States
  • ADM United States
  • Employees
  • NTRA N/A
  • ADM N/A
  • Industry
  • NTRA Medical Specialities
  • ADM Packaged Foods
  • Sector
  • NTRA Health Care
  • ADM Consumer Staples
  • Exchange
  • NTRA Nasdaq
  • ADM Nasdaq
  • Market Cap
  • NTRA 21.5B
  • ADM 23.1B
  • IPO Year
  • NTRA 2015
  • ADM N/A
  • Fundamental
  • Price
  • NTRA $171.86
  • ADM $53.61
  • Analyst Decision
  • NTRA Strong Buy
  • ADM Hold
  • Analyst Count
  • NTRA 16
  • ADM 6
  • Target Price
  • NTRA $185.56
  • ADM $49.67
  • AVG Volume (30 Days)
  • NTRA 1.2M
  • ADM 3.5M
  • Earning Date
  • NTRA 08-07-2025
  • ADM 07-29-2025
  • Dividend Yield
  • NTRA N/A
  • ADM 3.82%
  • EPS Growth
  • NTRA N/A
  • ADM N/A
  • EPS
  • NTRA N/A
  • ADM 2.81
  • Revenue
  • NTRA $1,831,000,000.00
  • ADM $83,858,000,000.00
  • Revenue This Year
  • NTRA $19.92
  • ADM N/A
  • Revenue Next Year
  • NTRA $16.02
  • ADM $2.73
  • P/E Ratio
  • NTRA N/A
  • ADM $19.01
  • Revenue Growth
  • NTRA 51.50
  • ADM N/A
  • 52 Week Low
  • NTRA $92.14
  • ADM $40.98
  • 52 Week High
  • NTRA $183.00
  • ADM $66.08
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 66.42
  • ADM 72.20
  • Support Level
  • NTRA $161.39
  • ADM $48.20
  • Resistance Level
  • NTRA $169.17
  • ADM $55.05
  • Average True Range (ATR)
  • NTRA 4.86
  • ADM 1.15
  • MACD
  • NTRA 0.57
  • ADM 0.66
  • Stochastic Oscillator
  • NTRA 90.95
  • ADM 82.52

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About ADM Archer-Daniels-Midland Company

Archer-Daniels-Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. The company is also one of the largest grain merchandisers through its extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients and is a large producer of corn-based sweeteners, starches, and ethanol.

Share on Social Networks: